Kestra Investment Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$220K Sell
2,399
-246
-9% -$21.5K ﹤0.01% 495
2026
Q1
$225K Buy
+2,645
New +$236K ﹤0.01% 417
2025
Q3
– Sell
-16,854
Closed -$1.53M – 482
2025
Q2
$1.53M Buy
16,854
+4,289
+34% +$392K 0.05% 136
2025
Q1
$1.18M Sell
12,565
-3,814
-23% -$342K 0.04% 150
2024
Q4
$1.49M Buy
16,379
+5,984
+58% +$571K 0.06% 105
2024
Q3
$1.08M Buy
+10,395
New +$1.06M 0.05% 116

Other funds holding CL

Kestra Investment Management's CL Position: Q2 2026 in Review

Kestra Investment Management reduced its Colgate-Palmolive (CL) stake by 9.3% in Q2 2026, selling an estimated $21.5K and leaving 2,399 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #495.

Kestra Investment Management first reported a position in CL in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.53M in Q2 2025. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Kestra Investment Management held 2,399 shares of Colgate-Palmolive worth $220K as of Q2 2026.
  • Kestra Investment Management sold 246 Colgate-Palmolive shares in Q2 2026, an estimated $21.5K.
  • Colgate-Palmolive made up ﹤0.01% of Kestra Investment Management's portfolio in Q2 2026, its #495 holding.
  • Kestra Investment Management first reported a position in Colgate-Palmolive in Q3 2024 and has held it in 6 quarters since.
  • Kestra Investment Management's Colgate-Palmolive position peaked at $1.53M in Q2 2025.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.